The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Diverticular Treatment-Global Market Insights and Sales Trends 2024
Synopsis
Diverticular disease is a digestive condition that leads to the formation of sacs or small bulges in the wall of the large intestine. These sacs can be formed anywhere in the colon, but it is majorly found in the sigmoid colon. Diverticular disease can be caused by many factors such as low fiber diet, lack of physical exercise, and certain medications like anti-inflammatory drugs, lack of vitamin D, obesity, and smoking.
The global Diverticular Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Diverticular Treatment in various end use industries. The expanding demands from the Diverticulosis and Diverticulitis, are propelling Diverticular Treatment market. Medication, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Supportive Care segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Diverticular Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Diverticular Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Diverticular Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Diverticular Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Diverticular Treatment covered in this report include Mallinckrodt, Bausch Health Companies Inc, Abbott Laboratories, Novartis AG, Ardelyx, Astellas Pharma Inc, Johnson & Johnson Services, Baxter and Pfizer, etc.
The global Diverticular Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Mallinckrodt
Bausch Health Companies Inc
Abbott Laboratories
Novartis AG
Ardelyx
Astellas Pharma Inc
Johnson & Johnson Services
Baxter
Pfizer
Teva Pharmaceutical Industries Ltd
Hikma Pharmaceuticals PLC
Neopharma
Aurobindo pharma
Bayer AG
Viatris
Fresenius Kabi USA
Global Diverticular Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diverticular Treatment market, Segment by Type:
Medication
Supportive Care
Surgery
Global Diverticular Treatment market, by Application
Diverticulosis
Diverticulitis
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Diverticular Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Diverticular disease is a digestive condition that leads to the formation of sacs or small bulges in the wall of the large intestine. These sacs can be formed anywhere in the colon, but it is majorly found in the sigmoid colon. Diverticular disease can be caused by many factors such as low fiber diet, lack of physical exercise, and certain medications like anti-inflammatory drugs, lack of vitamin D, obesity, and smoking.
The global Diverticular Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Diverticular Treatment in various end use industries. The expanding demands from the Diverticulosis and Diverticulitis, are propelling Diverticular Treatment market. Medication, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Supportive Care segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Diverticular Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Diverticular Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Diverticular Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Diverticular Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Diverticular Treatment covered in this report include Mallinckrodt, Bausch Health Companies Inc, Abbott Laboratories, Novartis AG, Ardelyx, Astellas Pharma Inc, Johnson & Johnson Services, Baxter and Pfizer, etc.
The global Diverticular Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Mallinckrodt
Bausch Health Companies Inc
Abbott Laboratories
Novartis AG
Ardelyx
Astellas Pharma Inc
Johnson & Johnson Services
Baxter
Pfizer
Teva Pharmaceutical Industries Ltd
Hikma Pharmaceuticals PLC
Neopharma
Aurobindo pharma
Bayer AG
Viatris
Fresenius Kabi USA
Global Diverticular Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diverticular Treatment market, Segment by Type:
Medication
Supportive Care
Surgery
Global Diverticular Treatment market, by Application
Diverticulosis
Diverticulitis
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Diverticular Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Diverticular Treatment
1.1 Diverticular Treatment Market Overview
1.1.1 Diverticular Treatment Product Scope
1.1.2 Diverticular Treatment Market Status and Outlook
1.2 Global Diverticular Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Diverticular Treatment Market Size by Region (2018-2029)
1.4 Global Diverticular Treatment Historic Market Size by Region (2018-2023)
1.5 Global Diverticular Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Diverticular Treatment Market Size (2018-2029)
1.6.1 North America Diverticular Treatment Market Size (2018-2029)
1.6.2 Europe Diverticular Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Diverticular Treatment Market Size (2018-2029)
1.6.4 Latin America Diverticular Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Diverticular Treatment Market Size (2018-2029)
2 Diverticular Treatment Market by Type
2.1 Introduction
2.1.1 Medication
2.1.2 Supportive Care
2.1.3 Surgery
2.2 Global Diverticular Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Diverticular Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Diverticular Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Diverticular Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Diverticular Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Diverticular Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Diverticular Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Diverticular Treatment Revenue Breakdown by Type (2018-2029)
3 Diverticular Treatment Market Overview by Application
3.1 Introduction
3.1.1 Diverticulosis
3.1.2 Diverticulitis
3.2 Global Diverticular Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Diverticular Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Diverticular Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Diverticular Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Diverticular Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Diverticular Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Diverticular Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Diverticular Treatment Revenue Breakdown by Application (2018-2029)
4 Diverticular Treatment Competition Analysis by Players
4.1 Global Diverticular Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diverticular Treatment as of 2022)
4.3 Date of Key Players Enter into Diverticular Treatment Market
4.4 Global Top Players Diverticular Treatment Headquarters and Area Served
4.5 Key Players Diverticular Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Diverticular Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Mallinckrodt
5.1.1 Mallinckrodt Profile
5.1.2 Mallinckrodt Main Business
5.1.3 Mallinckrodt Diverticular Treatment Products, Services and Solutions
5.1.4 Mallinckrodt Diverticular Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Mallinckrodt Recent Developments
5.2 Bausch Health Companies Inc
5.2.1 Bausch Health Companies Inc Profile
5.2.2 Bausch Health Companies Inc Main Business
5.2.3 Bausch Health Companies Inc Diverticular Treatment Products, Services and Solutions
5.2.4 Bausch Health Companies Inc Diverticular Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Bausch Health Companies Inc Recent Developments
5.3 Abbott Laboratories
5.3.1 Abbott Laboratories Profile
5.3.2 Abbott Laboratories Main Business
5.3.3 Abbott Laboratories Diverticular Treatment Products, Services and Solutions
5.3.4 Abbott Laboratories Diverticular Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Novartis AG Recent Developments
5.4 Novartis AG
5.4.1 Novartis AG Profile
5.4.2 Novartis AG Main Business
5.4.3 Novartis AG Diverticular Treatment Products, Services and Solutions
5.4.4 Novartis AG Diverticular Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Novartis AG Recent Developments
5.5 Ardelyx
5.5.1 Ardelyx Profile
5.5.2 Ardelyx Main Business
5.5.3 Ardelyx Diverticular Treatment Products, Services and Solutions
5.5.4 Ardelyx Diverticular Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Ardelyx Recent Developments
5.6 Astellas Pharma Inc
5.6.1 Astellas Pharma Inc Profile
5.6.2 Astellas Pharma Inc Main Business
5.6.3 Astellas Pharma Inc Diverticular Treatment Products, Services and Solutions
5.6.4 Astellas Pharma Inc Diverticular Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Astellas Pharma Inc Recent Developments
5.7 Johnson & Johnson Services
5.7.1 Johnson & Johnson Services Profile
5.7.2 Johnson & Johnson Services Main Business
5.7.3 Johnson & Johnson Services Diverticular Treatment Products, Services and Solutions
5.7.4 Johnson & Johnson Services Diverticular Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Johnson & Johnson Services Recent Developments
5.8 Baxter
5.8.1 Baxter Profile
5.8.2 Baxter Main Business
5.8.3 Baxter Diverticular Treatment Products, Services and Solutions
5.8.4 Baxter Diverticular Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Baxter Recent Developments
5.9 Pfizer
5.9.1 Pfizer Profile
5.9.2 Pfizer Main Business
5.9.3 Pfizer Diverticular Treatment Products, Services and Solutions
5.9.4 Pfizer Diverticular Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Pfizer Recent Developments
5.10 Teva Pharmaceutical Industries Ltd
5.10.1 Teva Pharmaceutical Industries Ltd Profile
5.10.2 Teva Pharmaceutical Industries Ltd Main Business
5.10.3 Teva Pharmaceutical Industries Ltd Diverticular Treatment Products, Services and Solutions
5.10.4 Teva Pharmaceutical Industries Ltd Diverticular Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Teva Pharmaceutical Industries Ltd Recent Developments
5.11 Hikma Pharmaceuticals PLC
5.11.1 Hikma Pharmaceuticals PLC Profile
5.11.2 Hikma Pharmaceuticals PLC Main Business
5.11.3 Hikma Pharmaceuticals PLC Diverticular Treatment Products, Services and Solutions
5.11.4 Hikma Pharmaceuticals PLC Diverticular Treatment Revenue (US$ Million) & (2018-2023)
5.11.5 Hikma Pharmaceuticals PLC Recent Developments
5.12 Neopharma
5.12.1 Neopharma Profile
5.12.2 Neopharma Main Business
5.12.3 Neopharma Diverticular Treatment Products, Services and Solutions
5.12.4 Neopharma Diverticular Treatment Revenue (US$ Million) & (2018-2023)
5.12.5 Neopharma Recent Developments
5.13 Aurobindo pharma
5.13.1 Aurobindo pharma Profile
5.13.2 Aurobindo pharma Main Business
5.13.3 Aurobindo pharma Diverticular Treatment Products, Services and Solutions
5.13.4 Aurobindo pharma Diverticular Treatment Revenue (US$ Million) & (2018-2023)
5.13.5 Aurobindo pharma Recent Developments
5.14 Bayer AG
5.14.1 Bayer AG Profile
5.14.2 Bayer AG Main Business
5.14.3 Bayer AG Diverticular Treatment Products, Services and Solutions
5.14.4 Bayer AG Diverticular Treatment Revenue (US$ Million) & (2018-2023)
5.14.5 Bayer AG Recent Developments
5.15 Viatris
5.15.1 Viatris Profile
5.15.2 Viatris Main Business
5.15.3 Viatris Diverticular Treatment Products, Services and Solutions
5.15.4 Viatris Diverticular Treatment Revenue (US$ Million) & (2018-2023)
5.15.5 Viatris Recent Developments
5.16 Fresenius Kabi USA
5.16.1 Fresenius Kabi USA Profile
5.16.2 Fresenius Kabi USA Main Business
5.16.3 Fresenius Kabi USA Diverticular Treatment Products, Services and Solutions
5.16.4 Fresenius Kabi USA Diverticular Treatment Revenue (US$ Million) & (2018-2023)
5.16.5 Fresenius Kabi USA Recent Developments
6 North America
6.1 North America Diverticular Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Diverticular Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Diverticular Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Diverticular Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Diverticular Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Diverticular Treatment Market Dynamics
11.1 Diverticular Treatment Industry Trends
11.2 Diverticular Treatment Market Drivers
11.3 Diverticular Treatment Market Challenges
11.4 Diverticular Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
